Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Alexandre A. de Castro, Flávia V. Soares, Ander F. Pereira, Daniel A. Polisel, Melissa S. Caetano, Daniel H. S. Leal, Elaine F. F. da Cunha, Eugenie Nepovimova, Kamil Kuca & Teodorico C. Ramalho. (2019) Non-conventional compounds with potential therapeutic effects against Alzheimer’s disease. Expert Review of Neurotherapeutics 19:5, pages 375-395.
Read now
Read now
Martin Broadstock, Clive Ballard & Anne Corbett. (2014) Latest treatment options for Alzheimer’s disease, Parkinson’s disease dementia and dementia with Lewy bodies. Expert Opinion on Pharmacotherapy 15:13, pages 1797-1810.
Read now
Read now
Anne Corbett & Clive Ballard. (2013) Is a potential Alzheimer's therapy already in use for other conditions? Can medications for hypertension, diabetes and acne help with the symptoms?. Expert Opinion on Investigational Drugs 22:8, pages 941-943.
Read now
Read now
Arwen Markwick, Giovanna Zamboni & CelesteA. de Jager. (2012) Profiles of cognitive subtest impairment in the Montreal Cognitive Assessment (MoCA) in a research cohort with normal Mini-Mental State Examination (MMSE) scores. Journal of Clinical and Experimental Neuropsychology 34:7, pages 750-757.
Read now
Read now
Anne Corbett & Clive Ballard. (2012) New and emerging treatments for Alzheimer's disease. Expert Opinion on Emerging Drugs 17:2, pages 147-156.
Read now
Read now
Articles from other publishers (12)
Dikshaa Padhi & Thimmaiah Govindaraju. (2022) Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease. Journal of Medicinal Chemistry 65:10, pages 7088-7105.
Crossref
Crossref
Leslie C. Norins. (2021) Repurposing Licensed Drugs for Use Against Alzheimer’s Disease. Journal of Alzheimer's Disease 81:3, pages 921-932.
Crossref
Crossref
Alessandra Amato, Giuseppe Messina, Valerio Giustino, Jessica Brusa, Filippo Brighina & Patrizia Proia. (2021) A pilot study on non-invasive treatment of migraine: The self-myofascial release. European Journal of Translational Myology.
Crossref
Crossref
Alessandra Amato, Giuseppe Messina, Valerio Giustino, Jessica Brusa, Filippo Brighina & Patrizia Proia. (2021) A pilot study on non-invasive treatment of migraine: The self-myofascial release. European Journal of Translational Myology.
Crossref
Crossref
Thanigaimalai Pillaiyar, Sangeetha Meenakshisundaram, Manoj Manickam & Murugesan Sankaranarayanan. (2020) A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery. European Journal of Medicinal Chemistry 195, pages 112275.
Crossref
Crossref
Sales, Prandi, Castro, Leal, Cunha, Kuca & Ramalho. (2019) Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments. International Journal of Molecular Sciences 20:8, pages 1829.
Crossref
Crossref
Mohammad Hosein Farzaei, Roodabeh Bahramsoltani, Zahra Abbasabadi, Nady Braidy & Seyed Mohammad Nabavi. (2018) Role of green tea catechins in prevention of age‐related cognitive decline: Pharmacological targets and clinical perspective. Journal of Cellular Physiology 234:3, pages 2447-2459.
Crossref
Crossref
Ernesto Tarragon, Dolores Lopez, Cristina Estrada, Ana Gonzalez-Cuello, Carmen Ma Ros, Yves Lamberty, Fabien Pifferi, Massimo Cella, Mara Canovi, Giovanna Guiso, Marco Gobbi, Emiliano Fernández-Villalba, Olivier Blin, Regis Bordet, Jill C. Richardson & María Trinidad Herrero. (2014) Memantine prevents reference and working memory impairment caused by sleep deprivation in both young and aged Octodon degus. Neuropharmacology 85, pages 206-214.
Crossref
Crossref
U. Richarz, M. Gaudig, K. Rettig & B. Schauble. (2014) Galantamine treatment in outpatients with mild Alzheimer's disease. Acta Neurologica Scandinavica 129:6, pages 382-392.
Crossref
Crossref
Mansi Patel, Anuradha Joshi, Jalpa Suthar & Soaham Desai. (2014) Drug Utilization Pattern in Patients with Different Types of Dementia in Western India. International Journal of Alzheimer's Disease 2014, pages 1-9.
Crossref
Crossref
Anne Corbett, Gareth Williams & Clive Ballard. (2013) Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease. Pharmaceuticals 6:10, pages 1304-1321.
Crossref
Crossref
Anne Corbett, James Pickett, Alistair Burns, Jonathan Corcoran, Stephen B. Dunnett, Paul Edison, Jim J. Hagan, Clive Holmes, Emma Jones, Cornelius Katona, Ian Kearns, Patrick Kehoe, Amrit Mudher, Anthony Passmore, Nicola Shepherd, Frank Walsh & Clive Ballard. (2012) Drug repositioning for Alzheimer's disease. Nature Reviews Drug Discovery 11:11, pages 833-846.
Crossref
Crossref